Pila Pharma AB (publ) (STO:PILA)
Sweden · Delayed Price · Currency is SEK 1.170
-0.095 (-7.51%)
Jul 24, 2026, 5:13 PM CET
Pila Pharma AB Market Cap
Pila Pharma AB has a market cap or net worth of 57.79 million as of July 24, 2026. Its market cap has decreased by -60.54% in one year.
Market Cap
57.79M
Enterprise Value
41.89M
Revenue
1.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.17
ChartMarket Cap Chart
Since July 15, 2021, Pila Pharma AB's market cap has decreased from 144.39M to 57.79M, a decrease of -59.98%. That is a compound annual growth rate of -16.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 53.45M | -38.35% |
| Dec 30, 2025 | 86.69M | -14.78% |
| Dec 30, 2024 | 101.72M | 167.21% |
| Dec 29, 2023 | 38.07M | -23.60% |
| Dec 29, 2022 | 49.83M | -54.49% |
| Dec 30, 2021 | 109.48M | -24.17% |
| Jul 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OncoZenge AB | 102.41M |
| Annexin Pharmaceuticals AB | 86.83M |
| Spago Nanomedical AB | 76.74M |
| AcouSort AB | 75.56M |
| Ascelia Pharma AB | 66.17M |
| 2cureX AB | 57.94M |
| Modus Therapeutics Holding AB | 43.30M |
| Fluicell AB | 41.49M |